These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20869343)

  • 1. The relationship between socioeconomic deprivation and metabolic/cardiovascular risk factors in a cohort of patients with type 2 diabetes mellitus.
    O'Kane MJ; McMenamin M; Bunting BP; Moore A; Coates VE
    Prim Care Diabetes; 2010 Dec; 4(4):241-9. PubMed ID: 20869343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic position and cardiovascular risk factors among people with screen-detected Type 2 DM: six-year follow-up of the ADDITION-Denmark trial.
    Dalsgaard EM; Vestergaard M; Skriver MV; Borch-Johnsen K; Lauritzen T; Sandbaek A
    Prim Care Diabetes; 2014 Dec; 8(4):322-9. PubMed ID: 24613817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study.
    Leśniak W; Bała MM; Płaczkiewicz-Jankowska E; Topór-Mądry R; Jankowski M; Sieradzki J; Banasiak W;
    Cardiol J; 2015; 22(2):150-9. PubMed ID: 25299503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social disparities in diabetes care: a general population study in Denmark.
    Heltberg A; Andersen JS; Kragstrup J; Siersma V; Sandholdt H; Ellervik C
    Scand J Prim Health Care; 2017 Mar; 35(1):54-63. PubMed ID: 28277046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage.
    Vázquez LA; Rodríguez Á; Salvador J; Ascaso JF; Petto H; Reviriego J
    BMC Cardiovasc Disord; 2014 Nov; 14():153. PubMed ID: 25361574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in Denmark.
    Safai N; Carstensen B; Vestergaard H; Ridderstråle M
    BMJ Open; 2018 Mar; 8(3):e019214. PubMed ID: 29550776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic control and therapeutic profile of patients with diabetes in Portuguese primary care (TEDDI CP).
    Cardoso SM; Rodrigues E; Valadas C; Fonseca C;
    Prim Care Diabetes; 2015 Jun; 9(3):172-8. PubMed ID: 25132139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease.
    Changsirikulchai S; Sangthawan P; Janma J; Sripaiboonkij N; Rattanamongkolgul S; Thinkhamrop B
    Nephrology (Carlton); 2018 Jan; 23(1):53-59. PubMed ID: 27608176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Prevalence of Vitamin D Deficiency and Correlation of Serum Vitamin D with Cardiovascular Risk in Patients with Metabolic Syndrome.
    Alkhatatbeh MJ; Abdul-Razzak KK; Khasawneh LQ; Saadeh NA
    Metab Syndr Relat Disord; 2017 Jun; 15(5):213-219. PubMed ID: 28346853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
    Wens J; Gerard R; Vandenberghe H
    Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
    Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
    Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalised treatment targets in type 2 diabetes patients: The Dutch approach.
    Boels AM; Hart HE; Rutten GE; Vos RC
    Prim Care Diabetes; 2017 Feb; 11(1):71-77. PubMed ID: 27633894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes Mellitus: A Population-Based Cohort Study Assessing Sex Disparities.
    Wright AK; Kontopantelis E; Emsley R; Buchan I; Mamas MA; Sattar N; Ashcroft DM; Rutter MK
    Circulation; 2019 Jun; 139(24):2742-2753. PubMed ID: 30986362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in cardiovascular risk factors in relation to diabetes status: the Tromso Study.
    Joseph J; Svartberg J; Njølstad I; Schirmer H
    Eur J Prev Cardiol; 2012 Jun; 19(3):551-7. PubMed ID: 21505026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus.
    Kautzky-Willer A; Kamyar MR; Gerhat D; Handisurya A; Stemer G; Hudson S; Luger A; Lemmens-Gruber R
    Gend Med; 2010 Dec; 7(6):571-83. PubMed ID: 21195357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A primary care register for impaired glucose handling (IGH): impact on cardiometabolic profile.
    Heald AH; Knapman H; Nair S; Chambers T; Radford D; Rushton T; Anderson SG
    Prim Care Diabetes; 2012 Oct; 6(3):213-9. PubMed ID: 22560663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-Related Differences in the Control of Cardiovascular Risk Factors in Primary Care for Elderly Patients With Type 2 Diabetes: A Cohort Study.
    Al-Salameh A; Bucher S; Bauduceau B; Benattar-Zibi L; Berrut G; Bertin P; Corruble E; Danchin N; Derumeaux G; Doucet J; Falissard B; Forette F; Hanon O; Ourabah R; Pasquier F; Pinget M; Ringa V; Becquemont L
    Can J Diabetes; 2018 Aug; 42(4):365-371.e2. PubMed ID: 29037572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
    Basile J; Houston M; Ferrario CM
    J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.